3 monkies
- 08 Feb 2011 19:17
RHPS has just mentioned the above in an e-mail, they have gone up 240% today - started at 0.60 and finished up at 1.65. Look to be quite interesting.
3 monkies
- 04 Mar 2011 09:25
- 66 of 224
Hope it leaks a lot more, in the right direction.
GILBERT01
- 04 Mar 2011 10:15
- 67 of 224
BUY SAR THE NEWS SHOWS IT IS GOING TO ROCKET
skinny
- 04 Mar 2011 10:21
- 69 of 224
No insider knowledge there then!
gibby
- 04 Mar 2011 10:46
- 70 of 224
yeeeeeeeeeeeeeeeeeeehaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
great rns - gonna end the day over 3p!!!!!
Sareum report positive tests on cancer drugs
StockMarketWire.com
Sareum, the specialist cancer drug discovery business, has announced positive results from pre-clinical in-vivo efficacy studies from their joint research collaboration with Cancer Research Technology and The Institute of Cancer Research.
A recent colon cancer pre-clinical model study carried out demonstrates that the combination of a collaboration Chk1 inhibitor, dosed via the oral route, in combination with a chemotherapeutic, gemcitabine, demonstrates a greater than two-fold reduction in cancer growth rate compared to treatment with the same dose of gemcitabine without the Chk1 inhibitor.
Sareum's CEO, Dr Tim Mitchell, commented: "These are exciting advances, demonstrating efficacy of our Chk1 compounds in several cancer models. Studies on additional models are on-going. We believe the results from the recently conducted studies will significantly enhance the licencing package and assist the collaboration in selecting the best compound for development into a clinical trials candidate".
required field
- 04 Mar 2011 11:59
- 71 of 224
Taken a punt in this, pure gamble....not sure at all....but will be patient (no pun), until decent profit emerges.....
required field
- 04 Mar 2011 12:17
- 72 of 224
Could easily go to 5p......volatile....
DD5
- 04 Mar 2011 16:27
- 73 of 224
Kudos to Gibby who quite accurately predicted the SP finishing over 3p today :p
Well done all those in at low levels
D
required field
- 04 Mar 2011 16:33
- 74 of 224
Small profit showing......will this turn out to be a star ?.....could go much further on monday !...
Balerboy
- 04 Mar 2011 16:34
- 75 of 224
3m's your luck might be in......keep watching.
3 monkies
- 04 Mar 2011 17:00
- 76 of 224
Who knows, throw a coin up in the air as they say - better than nothing though, keep everything crossed this weekend and see what happens. Balerboy I sold PVC - lost 52.50, I spied my chance and sold for 0.52 - watch this space they will go up now haah!! I'm not bothered I'm out. My friend made a few bob this morning with sar which I am more than pleased for her.
Have a good weekend all.
3 monkies
- 04 Mar 2011 17:15
- 77 of 224
Sorry I meant PYC - did you get out ballerboy?
Balerboy
- 04 Mar 2011 22:15
- 78 of 224
missed it, had to go out.....sods law..lol
3 monkies
- 04 Mar 2011 22:59
- 79 of 224
I really hope that my luck is in with Sar BECAUSE IF EVER I MAKE A PROFIT
Balerboy
- 04 Mar 2011 23:14
- 80 of 224
we'll meet in yr local.....
3 monkies
- 04 Mar 2011 23:24
- 81 of 224
You might have a long way to travel and your pouch might not get on with mine oh dear too many gins uuuupppppppsssssssssssss.
tabasco
- 05 Mar 2011 07:46
- 82 of 224
Drug group Sareum soars on cancer inhibitor news
Sareum, an Aim-listed drug discovery company, has more than doubled after positive results from a pre-clinical trial of its cancer treatment.
The company's Chk1 inhibitor, when combined with chemotherapeutic drugs, showed a more than two fold reduction in cancer growth rates, compared to using the chemotherapeutic alone. The cancer growth inhibitor was developed in collaboration with Cancer Research Technology and the Institute of Cancer Research. Sareum chief executive Tim Mitchell said the studies demonstrated the efficacy of its compounds in several cancer models, and trials on other models were continuing. These are still early stages - there is no licensing agreement as yet for example - but Mitchell said:
We believe the results from the recently conducted studies will significantly enhance the licensing package and assist the collaboration in selecting the best compound for development into a clinical trials candidate.
Early stage or not, the market likes the latest developments, and Sareum's shares have jumped 1.34p to 2.39p.
http://www.guardian.co.uk/business/marketforceslive/2011/mar/04/sareum-soars-cancer-inhibitor
http://www.growthcompany.co.uk/news/1607738/sareum-announce-latest-update.thtml
tabasco
- 05 Mar 2011 07:51
- 83 of 224
In the know: Capita, Sareum Holdings
* The Times
* Published: 05 March 2011
* Markets
...sector business. . Tiddler to watch Shares in Sareum Holdings more than doubled, rising 1p to 2p, after the drug discovery company said that its cancer growth inhibitor...
tabasco
- 05 Mar 2011 07:59
- 84 of 224
I think the word flat was a typo..lol some coverage today though...
MARKET REPORT by GEOFF FOSTER:
Cancer drug discovery company Sareum was flat at 2.38p after revealing that its cancer growth inhibitor therapy had shown positive results in pre-clinical trials. Apparently, when its inhibitor was combined with chemotherapeutic drugs it had led to a greater reduction in the growth rate of colon cancer than did the drugs alone.
Read more: http://www.dailymail.co.uk/money/article-1363155/MARKET-REPORT-GEOFF-FOSTER-ITV-tunes-Footsie-elite.html#ixzz1Fi3ymTMp
required field
- 05 Mar 2011 08:30
- 85 of 224
double post.